Werner Milton H.
- SEC CIK
- 0001827621
No open-market purchases or sales filed in the past year.
Current role at each company
- IKT Inhibikase Therapeutics, Inc.President and CEOas of Jan 22, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Werner Milton H. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 (view filing) | Aug 16 | Same day | Werner Milton H.President and CEO | PPurchase | +5.00K | $0.80 | +$4.00K | +0.1%5.34M after | |
| May 31, 2022 (view filing) | May 27 | 4 days | Werner Milton H.President and CEO | PPurchase | +5.00K | $0.98 | +$4.90K | +0.1%5.33M after | |
| May 23, 2022 (view filing) | May 20 | 3 days | Werner Milton H.President and CEO | PPurchase | +10.0K | $0.60 | +$6.00K | +0.2%5.33M after | |
| Nov 19, 2021 (view filing) | Nov 17 | 2 days | Werner Milton H.President and CEO | PPurchase | +23.6K | $1.97 | +$46.6K | New position23.6K after | 5 lots |